These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1671122)

  • 1. Transfusion requirements and effects in patients with thalassaemia major. Cooleycare Programme.
    Rebulla P; Modell B
    Lancet; 1991 Feb; 337(8736):277-80. PubMed ID: 1671122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfusion reactions in thalassemia. A survey from the Cooleycare programme. The Cooleycare Cooperative Group.
    Rebulla P
    Haematologica; 1990; 75 Suppl 5():122-7. PubMed ID: 2086372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Cell Alloantibodies in Thalassaemia Patients Who Received Ten or More Units of Transfusion.
    Sarkar SK; Shah MS; Begum M; Yunus AM; Aziz MA; Kabir AL; Khan MR; Rahman F; Rahman A
    Mymensingh Med J; 2019 Apr; 28(2):364-369. PubMed ID: 31086152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
    Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
    Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia.
    Thompson AA; Cunningham MJ; Singer ST; Neufeld EJ; Vichinsky E; Yamashita R; Giardina P; Kim HY; Trachtenberg F; Kwiatkowski JL;
    Br J Haematol; 2011 Apr; 153(1):121-8. PubMed ID: 21323889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemoglobin levels and blood requirement in thalassaemia.
    Gabutti V; Piga A; Nicola P; Vullo C; Capra L; Di Palma A; Masera G; Terzoli S; Mauri R
    Arch Dis Child; 1982 Feb; 57(2):156-8. PubMed ID: 7065714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.
    Singer ST; Wu V; Mignacca R; Kuypers FA; Morel P; Vichinsky EP
    Blood; 2000 Nov; 96(10):3369-73. PubMed ID: 11071629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients.
    Guirat-Dhouib N; Mezri M; Hmida H; Mellouli F; Kaabi H; Ouderni M; Zouari B; Hmida S; Bejaoui M
    Transfus Apher Sci; 2011 Oct; 45(2):199-202. PubMed ID: 21889408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy in homozygous beta thalassaemia: a retrospective study of 30 patients.
    Engelhard D; Cividalli G; Rachmilewitz EA
    Br J Haematol; 1975 Nov; 31(3):391-403. PubMed ID: 1201250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion requirements and splenectomy in thalassemia major.
    Cohen A; Markenson AL; Schwartz E
    J Pediatr; 1980 Jul; 97(1):100-2. PubMed ID: 7381628
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective trial of young red cells in 48 patients with transfusion-dependent thalassaemia.
    Marcus RE; Wonke B; Bantock HM; Thomas MJ; Parry ES; Taite H; Huehns ER
    Br J Haematol; 1985 May; 60(1):153-9. PubMed ID: 4005175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of splenectomy on transfusion requirements in thalassemia major.
    Cohen A; Gayer R; Mizanin J
    Am J Hematol; 1989 Apr; 30(4):254-6. PubMed ID: 2929586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between transfusion requirement, blood volume and haemoglobin level in homozygous beta-thalassaemia.
    Gabutti V; Piga A; Fortina P; Miniero R; Nicola P
    Acta Haematol; 1980; 64(2):103-8. PubMed ID: 6776764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program.
    el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS
    Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transfusion requirements and mean annual hemoglobin level in thalassemia major].
    Brunengo MA; Girot R
    Nouv Rev Fr Hematol (1978); 1986; 28(5):309-13. PubMed ID: 3808940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias.
    Thedsawad A; Taka O; Wanachiwanawin W
    Hematology; 2019 Dec; 24(1):208-214. PubMed ID: 30479186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample acceptance time criteria, electronic issue and alloimmunisation in thalassaemia.
    Trompeter S; Baxter L; McBrearty M; Zatkya E; Porter J
    Transfus Med; 2015 Dec; 25(6):414-7. PubMed ID: 26593684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial splenectomy in homozygous beta thalassaemia.
    de Montalembert M; Girot R; Revillon Y; Jan D; Adjrad L; Ardjoun FZ; Belhani M; Najean Y
    Arch Dis Child; 1990 Mar; 65(3):304-7. PubMed ID: 2334210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.